ACADIA Pharmaceuticals Inc (ACAD)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 319,589 | 155,149 | 177,134 | 204,745 | 188,657 | 98,193 | 107,941 | 290,895 | 114,846 | 154,842 | 139,833 | 204,920 | 147,435 | 94,640 | 266,956 | 304,487 | 326,028 | 452,352 | 310,441 | 173,059 |
| Short-term investments | US$ in thousands | 436,404 | 410,181 | 323,808 | 265,775 | 250,208 | 247,727 | 267,437 | 111,978 | 301,977 | 281,737 | 296,518 | 241,057 | 373,271 | 445,651 | 289,962 | 273,281 | 305,930 | 192,089 | 348,110 | 478,347 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 394,870 | 343,945 | 337,851 | 330,597 | 254,254 | 209,603 | 187,942 | 224,301 | 125,630 | 116,570 | 117,681 | 119,603 | 96,068 | 88,218 | 95,328 | 109,373 | 105,967 | 91,856 | 86,422 | 99,741 |
| Quick ratio | 1.91 | 1.64 | 1.48 | 1.42 | 1.73 | 1.65 | 2.00 | 1.80 | 3.32 | 3.75 | 3.71 | 3.73 | 5.42 | 6.12 | 5.84 | 5.28 | 5.96 | 7.02 | 7.62 | 6.53 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($319,589K
+ $436,404K
+ $—K)
÷ $394,870K
= 1.91
The quick ratio of ACADIA Pharmaceuticals Inc has shown a declining trend over the respective periods. Starting at a high of 6.53 as of March 31, 2020, the quick ratio steadily decreased to 1.42 as of March 31, 2024.
A quick ratio above 1 indicates that the company has sufficient liquid assets to cover its current liabilities. Therefore, ACADIA Pharmaceuticals Inc had a comfortable liquidity position initially. However, the declining trend suggests a potential concern as the ratio dipped below 1, reaching 1.42 as of March 31, 2024. This could indicate that the company may face challenges in meeting its short-term obligations with its available liquid assets.
It is important for stakeholders to monitor the quick ratio closely as a declining trend may signal liquidity issues that could impact the company's financial health and operational capabilities. It may be necessary for the company to assess its liquidity management strategies to ensure it can meet its short-term financial obligations effectively.
Peer comparison
Dec 31, 2024